Connect with us

Health

PharmAust secures Walter and Eliza Hall Institute as partner for HTLV-1 study – The West Australian

Perth-listed biotech PharmAust will investigate a treatment for a cancer-inducing virus through a new partnership with the Walter…

Published

on

Article feature image
Continue Reading
Advertisement
Advertisement

Trending